Nuveen LLC Invests $10.83 Million in Exponent, Inc. $EXPO

Key Points

• Nuveen LLC has acquired a new stake in Exponent, Inc., purchasing 133,583 shares valued at approximately $10.8 million, representing about 0.26% of the company's stock.
• Exponent's stock recently reported a 2.6% increase, with a current share price of $72.29 and a market capitalization of $3.65 billion.
• The company announced a quarterly dividend of $0.30, translating to an annual yield of 1.7%, with the payout date set for September 19th.

Nuveen LLC purchased a new stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 133,583 shares of the business services provider's stock, valued at approximately $10,828,000. Nuveen LLC owned 0.26% of Exponent at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in EXPO. Geneva Capital Management LLC increased its stake in shares of Exponent by 11.2% in the first quarter. Geneva Capital Management LLC now owns 1,745,828 shares of the business services provider's stock valued at $141,517,000 after buying an additional 176,152 shares in the last quarter. BLI Banque de Luxembourg Investments acquired a new stake in shares of Exponent in the fourth quarter valued at $12,564,000. Edgestream Partners L.P. boosted its holdings in Exponent by 367.2% in the first quarter. Edgestream Partners L.P. now owns 76,273 shares of the business services provider's stock valued at $6,183,000 after acquiring an additional 59,947 shares during the last quarter. Northern Trust Corp boosted its holdings in Exponent by 7.4% in the fourth quarter. Northern Trust Corp now owns 770,270 shares of the business services provider's stock valued at $68,631,000 after acquiring an additional 53,227 shares during the last quarter. Finally, Ameriprise Financial Inc. boosted its holdings in Exponent by 7.3% in the fourth quarter. Ameriprise Financial Inc. now owns 646,026 shares of the business services provider's stock valued at $57,561,000 after acquiring an additional 44,002 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Exponent Stock Performance

EXPO traded up $0.99 during midday trading on Wednesday, reaching $72.72. 191,412 shares of the company were exchanged, compared to its average volume of 322,112. Exponent, Inc. has a one year low of $63.81 and a one year high of $115.75. The stock has a market capitalization of $3.67 billion, a P/E ratio of 36.36 and a beta of 0.89. The stock's 50-day simple moving average is $72.69 and its 200 day simple moving average is $77.71.

Exponent (NASDAQ:EXPO - Get Free Report) last issued its earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The firm had revenue of $132.87 million for the quarter, compared to analysts' expectations of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The company's revenue was up 7.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.57 earnings per share. On average, research analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current year.

Exponent Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, September 19th. Shareholders of record on Friday, September 5th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, September 5th. This represents a $1.20 annualized dividend and a dividend yield of 1.7%. Exponent's payout ratio is 60.00%.

Insider Activity at Exponent

In related news, VP Joseph Sala sold 1,595 shares of the business's stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Catherine Corrigan sold 4,896 shares of Exponent stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $71.09, for a total value of $348,056.64. Following the completion of the transaction, the chief executive officer directly owned 81,342 shares of the company's stock, valued at $5,782,602.78. This represents a 5.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.